Barinthus Biotherapeutics plc
BRNS
$0.63
-$0.01-1.39%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 70.46M | 74.27M | 86.26M | 99.12M | 110.66M |
| Total Receivables | 1.31M | 4.89M | 5.01M | 3.86M | 7.14M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.52M | 5.41M | 6.35M | 5.01M | 5.86M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.51M | 2.20M | 2.79M | 1.90M | 2.08M |
| Total Current Assets | 77.79M | 86.78M | 100.41M | 109.88M | 125.74M |
|
|
|||||
| Total Current Assets | 77.79M | 86.78M | 100.41M | 109.88M | 125.74M |
| Net Property, Plant & Equipment | 5.16M | 6.58M | 7.84M | 10.06M | 11.76M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 14.29M | 14.91M | 20.37M | 21.16M | 21.95M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 930.00K | 929.00K | 944.00K | 902.00K | 881.00K |
| Total Assets | 98.17M | 109.20M | 129.56M | 142.00M | 160.33M |
|
|
|||||
| Total Accounts Payable | 350.00K | 698.00K | 1.80M | 1.36M | 2.47M |
| Total Accrued Expenses | 6.25M | 6.68M | 7.36M | 7.20M | 9.53M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.02M | 2.02M | 2.04M | 1.96M | 1.92M |
| Total Finance Division Other Current Liabilities | 1.40M | 1.40M | 1.53M | 1.46M | 1.74M |
| Total Other Current Liabilities | 1.40M | 1.40M | 1.53M | 1.46M | 1.74M |
| Total Current Liabilities | 10.02M | 10.80M | 12.73M | 11.98M | 15.66M |
|
|
|||||
| Total Current Liabilities | 10.02M | 10.80M | 12.73M | 11.98M | 15.66M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 9.26M | 9.55M | 9.95M | 9.96M | 10.09M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.60M | 4.29M | 4.40M | 4.47M | 4.45M |
| Total Liabilities | 23.88M | 24.64M | 27.08M | 26.40M | 30.19M |
|
|
|||||
| Common Stock & APIC | 393.95M | 393.25M | 393.66M | 393.95M | 393.48M |
| Retained Earnings | -304.09M | -293.00M | -278.44M | -257.31M | -237.66M |
| Treasury Stock & Other | -15.65M | -15.78M | -12.85M | -21.14M | -25.78M |
| Total Common Equity | 74.21M | 84.47M | 102.38M | 115.49M | 130.03M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 74.21M | 84.47M | 102.38M | 115.49M | 130.03M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 84.00K | 96.00K | 104.00K | 99.00K | 106.00K |
| Total Equity | 74.29M | 84.56M | 102.48M | 115.59M | 130.14M |
|
|
|||||